173 related articles for article (PubMed ID: 21962096)
1. Variations in expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in nasal mucosa of aspirin-sensitive versus aspirin-tolerant patients with nasal polyposis.
Mudd PA; Katial RK; Alam R; Hohensee S; Ramakrishnan V; Kingdom TT
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):353-9. PubMed ID: 21962096
[TBL] [Abstract][Full Text] [Related]
2. Distribution of matrix metalloproteinases MMP-1, MMP-2, MMP-8 and tissue inhibitor of matrix metalloproteinases-2 in nasal polyposis and chronic rhinosinusitis.
Eyibilen A; Cayli S; Aladag I; Koç S; Gurbuzler L; Atay GA
Histol Histopathol; 2011 May; 26(5):615-21. PubMed ID: 21432777
[TBL] [Abstract][Full Text] [Related]
3. The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis.
Can IH; Ceylan K; Caydere M; Samim EE; Ustun H; Karasoy DS
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):211-5. PubMed ID: 18656717
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their impact on sinusal extension in chronic rhinosinusitis with nasal polyps.
Malinsky RR; Valera FC; Cavallari FE; Küpper DS; Milaneze C; Silva JS; Tamashiro E; Anselmo-Lima WT
Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1345-8. PubMed ID: 23064462
[TBL] [Abstract][Full Text] [Related]
5. The role of MMP-2, MMP-9, and TIMP-1 in the pathogenesis of nasal polyps: Immunohistochemical assessment at eight different levels in the epithelial, subepithelial, and deep layers of the mucosa.
Muluk NB; Arikan OK; Atasoy P; Kiliç R; Yalçinozan ET
Ear Nose Throat J; 2015; 94(4-5):E1-13. PubMed ID: 25923279
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of remodeling markers by tissue structure in nasal polyposis.
de Borja Callejas F; Picado C; Martínez-Antón A; Alobid I; Pujols L; Valero A; Roca-Ferrer J; Mullol J
Am J Rhinol Allergy; 2013; 27(3):e69-74. PubMed ID: 23710947
[TBL] [Abstract][Full Text] [Related]
7. Nonasthmatic nasal polyposis patients with allergy exhibit greater epithelial MMP positivity.
Shin HW; Han DH; Lim YS; Kim HJ; Kim DY; Lee CH; Min YG; Rhee CS
Otolaryngol Head Neck Surg; 2009 Oct; 141(4):442-7. PubMed ID: 19786210
[TBL] [Abstract][Full Text] [Related]
8. Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma.
Katainen E; Kostamo K; Virkkula P; Sorsa T; Tervahartiala T; Haapaniemi A; Toskala E
Int Forum Allergy Rhinol; 2015 Apr; 5(4):294-302. PubMed ID: 25653042
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 1 in nonrecurrent vs recurrent nasal polyps.
Yeo NK; Eom DW; Oh MY; Lim HW; Song YJ
Ann Allergy Asthma Immunol; 2013 Sep; 111(3):205-10. PubMed ID: 23987197
[TBL] [Abstract][Full Text] [Related]
10. Relationship between matrix metalloproteinases MMP-2, MMP-9, tissue inhibitor of matrix metalloproteinases-1 and IL-5, IL-8 in nasal polyps.
Chen YS; Langhammer T; Westhofen M; Lorenzen J
Allergy; 2007 Jan; 62(1):66-72. PubMed ID: 17156344
[TBL] [Abstract][Full Text] [Related]
11. The role of MMP-9 and TIMP-1 in nasal polyp formation.
Kahveci OK; Derekoy FS; Yilmaz M; Serteser M; Altuntas A
Swiss Med Wkly; 2008 Nov; 138(45-46):684-8. PubMed ID: 19043814
[TBL] [Abstract][Full Text] [Related]
12. [The protein expression difference of transforming growth factor beta1, matrix metalloproteinases 1,7,9 and tissue inhibitors of matrix metalloproteinases-1 between chronic rhinosinusitis, nasal polyps and normal mucosa tissues].
Lu X; Liu Z; Cui Y
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):633-5. PubMed ID: 16248458
[TBL] [Abstract][Full Text] [Related]
13. Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis.
Wang LF; Chien CY; Chiang FY; Chai CY; Tai CF
Am J Rhinol Allergy; 2012; 26(1):e1-4. PubMed ID: 22391064
[TBL] [Abstract][Full Text] [Related]
14. Metalloproteinase function in chronic rhinosinusitis with nasal polyposis.
Kostamo K; Tervahartiala T; Sorsa T; Richardson M; Toskala E
Laryngoscope; 2007 Apr; 117(4):638-43. PubMed ID: 17429873
[TBL] [Abstract][Full Text] [Related]
15. Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Chronic Rhinosinusitis With Nasal Polyps: Etiopathogenesis and Recurrence.
Guerra G; Testa D; Salzano FA; Tafuri D; Hay E; Schettino Bs A; Iovine R; Marcuccio G; Motta G
Ear Nose Throat J; 2021 Sep; 100(5_suppl):597S-605S. PubMed ID: 31893934
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis.
Watelet JB; Bachert C; Claeys C; Van Cauwenberge P
Allergy; 2004 Jan; 59(1):54-60. PubMed ID: 14674934
[TBL] [Abstract][Full Text] [Related]
17. Rhinovirus upregulates matrix metalloproteinase-2, matrix metalloproteinase-9, and vascular endothelial growth factor expression in nasal polyp fibroblasts.
Wang JH; Kwon HJ; Jang YJ
Laryngoscope; 2009 Sep; 119(9):1834-8. PubMed ID: 19572270
[TBL] [Abstract][Full Text] [Related]
18. Different effects of allergic rhinitis on nasal mucosa remodeling in chronic rhinosinusitis with and without nasal polyps.
Xiang R; Zhang QP; Zhang W; Kong YG; Tan L; Chen SM; Deng YQ; Tao ZZ; Xu Y
Eur Arch Otorhinolaryngol; 2019 Jan; 276(1):115-130. PubMed ID: 30446828
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis.
Shaida A; Kenyon G; Devalia J; Davies RJ; MacDonald TT; Pender SL
J Allergy Clin Immunol; 2001 Nov; 108(5):791-6. PubMed ID: 11692106
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil inflammation of nasal polyp tissue: relationships with matrix metalloproteinases, tissue inhibitor of metalloproteinase-1, and transforming growth factor-beta1.
Lee YM; Kim SS; Kim HA; Suh YJ; Lee SK; Nahm DH; Park HS
J Korean Med Sci; 2003 Feb; 18(1):97-102. PubMed ID: 12589095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
